Clinical Trials Browser

Phase 1/2 × Completed × abiraterone × Clear all

NCT03480646 2025-10-29

ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1/2 Completed

175 enrolled 23 charts

Neoplasms

NCT01848067 2025-05-04

Alisertib, Abiraterone Acetate and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer

Phase 1/2 Completed

9 enrolled 9 charts

Prostatic Neoplasms

NCT01780220 2022-05-19

CARLHA

Phase 1/2 Completed

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy